COH – UBS rates the stock as Sell

By Broker News | More Articles by Broker News

The broker has updated FX forecasts. The stronger Australian dollar since January has a negative earnings translation impact for Cochlear. The FY15 earnings forecasts are downgraded by 4.5%.

The Sell rating and $48.00 target are maintained.

Sector: Health Care Equipment & Services.

Target price is $48.00.Current Price is $57.65. Difference: ($9.65) – (brackets indicate current price is over target). If COH meets the UBS target it will return approximately -20% (excluding dividends, fees and charges – negative figures indicate an expected loss).

Broker News

About Broker News

FNArena's Australian Broker Call, is your daily news report on the latest recommendation, valuation, forecast and opinions recently published by Stockbrokers.

View more articles by Broker News →